Bruce D. Levy

Bruce D. Levy

Intensive Care Medicine
15 Francis Street
2nd Floor
Boston, MA 02115

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 247 publications

Consumed with Inflammation.

Consumed with Inflammation.

Journal: The New England journal of medicine
Published: August 05, 2026

Aberrant mucin expression and keratinization distinguishing severe from mild asthma revealed by interpretable machine learning.

Aberrant mucin expression and keratinization distinguishing severe from mild asthma revealed by interpretable machine learning.

Journal: JCI insight
Published: July 30, 2026

The Unusual Suspects.

The Unusual Suspects.

Journal: The New England journal of medicine
Published: June 03, 2026

Cutting to the Chase.

Cutting to the Chase.

Journal: The New England journal of medicine
Published: May 27, 2026

Resolvin D5 limits inflammatory lung injury and enhances antibacterial host defense in severe pneumococcal pneumonia.

Resolvin D5 limits inflammatory lung injury and enhances antibacterial host defense in severe pneumococcal pneumonia.

Journal: Clinical science (London, England : 1979)
Published: May 13, 2026

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: The Lancet. Infectious diseases
Published: April 05, 2026

Polyunsaturated fatty acids modulation of smoking-related epigenetics and pulmonary outcomes.

Polyunsaturated fatty acids modulation of smoking-related epigenetics and pulmonary outcomes.

Journal: Genes & nutrition
Published: March 20, 2026

Developing a platform protocol for clinical trials evaluating interventions that target proposed mechanisms of Long COVID: RECOVER-VITAL.

Developing a platform protocol for clinical trials evaluating interventions that target proposed mechanisms of Long COVID: RECOVER-VITAL.

Journal: Clinical trials (London, England)
Published: March 06, 2026

Lower plasma resolvin D1 level and greater sputum eosinophilia characterize a cluster of severe asthma patients.

Lower plasma resolvin D1 level and greater sputum eosinophilia characterize a cluster of severe asthma patients.

Journal: Respiratory research
Published: March 02, 2026

Sustained Reduction in Cardiopulmonary Fitness in Long COVID: A Report from the RECOVER-adult Cohort Study.

Sustained Reduction in Cardiopulmonary Fitness in Long COVID: A Report from the RECOVER-adult Cohort Study.

Journal: JACC. Advances
Published: February 02, 2026

Persistent Immune Dysregulation during Long COVID is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins.

Persistent Immune Dysregulation during Long COVID is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins.

Journal: Research square
Published: January 16, 2026

Siglec-F+ neutrophils promote the resolution of acute lung injury through ALOX15 induction.

Siglec-F+ neutrophils promote the resolution of acute lung injury through ALOX15 induction.

Journal: Science immunology
Published: December 19, 2025
Showing 1-12 of 247

Last Updated: 09/26/2026